Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Digestive System Neoplasms × regorafenib × 1 year × Clear all

Sponsor

Conditions

Colorectal Neoplasms 29 Carcinoma, Hepatocellular 12 Glioblastoma 5 Colonic Neoplasms 5 Sarcoma, Ewing 3 Rectal Neoplasms 3 Osteosarcoma 3 Neoplasm Metastasis 3 Liver Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Leukemia, Myeloid, Acute 2 Gastrointestinal Stromal Tumors 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Chondrosarcoma 2 Astrocytoma 2 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Spinocerebellar Degenerations 1 Solid Malignant Tumors 1 Small Cell Lung Carcinoma 1 Recurrence 1 Patient Compliance 1 Pathologic Complete Response 1 Ovarian Neoplasms 1 Neoplasms 1 Myelodysplastic Syndromes 1

Interventions

Bevacizumab 4 Irinotecan 2 Cetuximab 2 Ascorbic Acid 2 tislelizumab 1 ribociclib 1 repotrectinib 1 pralsetinib 1 palbociclib 1 olaparib 1 fludarabine 1 encorafenib 1 durvalumab 1 dostarlimab 1 atezolizumab 1 Stem Cell Transplantation 1 Sirolimus 1 Ramucirumab 1 Radiotherapy 1 Paclitaxel 1 Oxaliplatin 1 Melphalan 1 Lutetium-177 1 Lutetium 1 Levoleucovorin 1 Leucovorin 1 Immunotherapy 1 Imatinib Mesylate 1 Hyperthermic Intraperitoneal Chemotherapy 1 Fulvestrant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡